Nirogacestat: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Nirogacestat. Educational only — not medical advice.
Labeled uses
OGSIVEO is indicated for adult patients with progressing desmoid tumors who require systemic treatment.
Source: FDA labeling via NIH DailyMed (set f172e6ff…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.